MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Prevalence and predictors of mood and health-related quality of life impairment among patients with parkinson’s in sub-saharan neurology clinic

U. Williams, S. Oparah, H. Okpa (Calabar, Nigeria)

Meeting: 2018 International Congress

Abstract Number: 1043

Keywords: Anxiety, Depression

Session Information

Date: Sunday, October 7, 2018

Session Title: Quality Of Life/Caregiver Burden in Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: This study was design to determine patient’s self-assessed health quality of life measures and mood. We also aimed at establishing the relationship between the health related quality of life and their demographic and clinical characteristics.

Background: Parkinson’s disease (PD) is a chronic neurodegerative disease that is characterized by motor and non-motor symptoms. It affects an estimated 4 million people worldwide. PD is associated with negative quality of life and mood disturbance that can affect the outcome of management.

Methods: Forty-nine consecutive consenting patients who presented at a Neurology clinic were evaluated using the Parkinson’s Disease Quality of Life Questionnaire (PDQ-39), the motor section of the Unified Parkinson’s Disease Rating Scale (UPDRS) and the Hospital Anxiety and Depression scale (HADS).

Results: The mean age of the patients was 61.27 years and the mean age at onset of symptoms was 57.65 years. They were made up of 73.5% males and 26.5 % females. The proportion with borderline anxiety, anxiety, borderline depression and depression were 8.2%, 4.1%, 22.4% and 4.1% respectively. Over 95% of the patients were above 40% on the Schwab and England activity of daily living scale, while over 60% of the patients were in stage 1 to 2.5 of the modified Hoehn and Yahr scale. The mean percentage scores for the elements of the PDQ39 among our patients were as follows: Mobility (MOB), 39.42%; Activities of Daily Living (ADL), 34.24%; Emotional wellbeing (EWB), 31.76%; Stigma (SG), 30.55%; Social Support (SS), 3.80%; Cognitive Impairment (CI), 22.71%; Communication (COM), 22.50% and Bodily Discomfort (BD) 32.18%. The PD summary Index (PDQ-I) for the group was 27.16%. We observed a significant correlation between anxiety scores on HADS with ADL, SS and BD (P value = 0.005, 0.016 and 0.045 respectively). For depression, significant correlation was observed for MOB and COM (P value = 0.041 and 0.003 respectively).

Conclusions: The prevalence of depression and anxiety was low among our cohort of PD patients. They had significantly high level of social support that contributed to a good quality of life reported by the patients.

To cite this abstract in AMA style:

U. Williams, S. Oparah, H. Okpa. Prevalence and predictors of mood and health-related quality of life impairment among patients with parkinson’s in sub-saharan neurology clinic [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/prevalence-and-predictors-of-mood-and-health-related-quality-of-life-impairment-among-patients-with-parkinsons-in-sub-saharan-neurology-clinic/. Accessed May 15, 2025.
  • Tweet
  • Email
  • Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/prevalence-and-predictors-of-mood-and-health-related-quality-of-life-impairment-among-patients-with-parkinsons-in-sub-saharan-neurology-clinic/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley